Zydus gets DCGI approval for emergency use of Virafin to treat moderate infection in adults
The DCGI has given approval to the Virafin drug by the Zydus to be used in an emergency to treat moderately affected adults. Reports have suggested that 91.15 per cent of people tested negative within seven days of its usage. The miracle drug comes amidst a huge shortage of medicines in the country.
The phase three trials will also bring in more life-saving drugs which could be helpful in bringing down the morbidity rate in the country. India stands second in the world in terms of the worst case of infections from all across the world.